Skip to main content
SpringerLink
Log in

Ventricular Arrhythmias in Patients After Myocardial Infarction

  • Chapter
Acute Coronary Syndrome

  • 1488 Accesses

Ventricular arrhythmias, ranging from premature ventricular contractions (PVCs) to ventricular fi brillation (VF), occur frequently in patients after acute myocardial infarction (AMI) [1]. The prognostic signifi cance of these arrhythmias as well as their optimal management is largely dependent on several factors (Table 18.1): time from AMI, type of ventricular arrhythmia, and extent of myocardial dysfunction. In this chapter, we discuss specifi c ventricular arrhythmias observed in patients after MI and their signifi cance, the impact of current medical therapy on the incidence of sudden cardiac death, and the role of antiarrhythmic drugs and implantable cardioverter-defi brillators in the management of post-MI patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Maggioni AP, Zuanetti G, Franzosi MG, et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation 1993;87:312–322.

    PubMed  CAS  Google Scholar 

  2. Andresen D, Bethge KP, Boissel JP, et al. Importance of quantitative analysis of ventricular arrhythmias for predicting the prognosis in low-risk postmyocardial infarction patients. European Infarction Study Group. Eur Heart J 1990;11:529–536.

    PubMed  CAS  Google Scholar 

  3. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004;44:671–719.

    Article  PubMed  Google Scholar 

  4. Dhurandhar RW, MacMillan RL, Brown KW. Primary ventricular fibrillation complicating acute myocardial infarction. Am J Cardiol 1971;27:347–351.

    Article  PubMed  CAS  Google Scholar 

  5. Gorgels AP, Vos MA, Letsch IS, et al. Usefulness of the accelerated idioventricular rhythm as a marker for myocardial necrosis and reperfusion during thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1988;61:231–235.

    Article  PubMed  CAS  Google Scholar 

  6. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48:e247–346.

    Article  PubMed  Google Scholar 

  7. Eldar M, Sievner Z, Goldbourt U, et al. Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality. The SPRINT Study Group. Ann Intern Med 1992;117:31–36.

    PubMed  CAS  Google Scholar 

  8. Heidbuchel H, Tack J, Vanneste L, et al. Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a beta-blocker or a bradycardiac agent on their incidence. Circulation 1994;89:1051–1059.

    PubMed  CAS  Google Scholar 

  9. Cheema AN, Sheu K, Parker M, et al. Nonsustained ventricular tachycardia in the setting of acute myocardial infarction: tachycardia characteristics and their prognostic implications. Circulation 1998;98:2030–2036.

    PubMed  CAS  Google Scholar 

  10. Mont L, Cinca J, Blanch P, et al. Predisposing factors and prognostic value of sustained monomorphic ventricular tachycardia in the early phase of acute myocardial infarction. J Am Coll Cardiol 1996;28:1670–1676.

    Article  PubMed  CAS  Google Scholar 

  11. Volpi A, Cavalli A, Santoro L, et al. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction—results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database. Am J Cardiol 1998;82:265–271.

    Article  PubMed  CAS  Google Scholar 

  12. Henkel DM, Witt BJ, Gersh BJ, et al. Ventricular arrhythmias after acute myocardial infarction: a 20-year community study. Am Heart J 2006;151:806–812.

    Article  PubMed  Google Scholar 

  13. Campbell RW, Murray A, Julian DG. Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural history study. Br Heart J 1981;46:351–357.

    Article  PubMed  CAS  Google Scholar 

  14. Dekker LR, Bezzina CR, Henriques JP, et al. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myo-cardial infarction patients. Circulation 2006;114:1140–1145.

    Article  PubMed  Google Scholar 

  15. Sadowski ZP, Alexander JH, Skrabucha B, et al. Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction. Am Heart J 1999; 137:792–798.

    Article  PubMed  CAS  Google Scholar 

  16. Norris RM, Barnaby PF, Brown MA, et al. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet 1984;2:883–886.

    Article  PubMed  CAS  Google Scholar 

  17. Reiter MJ, Reiffel JA. Importance of beta blockade in the therapy of serious ventricular arrhythmias. Am J Cardiol 1998;82:9I–19I.

    Article  PubMed  CAS  Google Scholar 

  18. Ellison KE, Hafley GE, Hickey K, et al. Effect of beta-blocking therapy on outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT). Circulation 2002;106:2694–2699.

    Article  PubMed  CAS  Google Scholar 

  19. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982;247:1707–1714.

    Article  Google Scholar 

  20. Hjalmarson A. Effects of beta blockade on sudden cardiac death during acute myo-cardial infarction and the postinfarction period. Am J Cardiol 1997;80:35J–39J.

    Article  PubMed  CAS  Google Scholar 

  21. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 1988;260:2088–2093.

    Article  PubMed  CAS  Google Scholar 

  22. Janosi A, Ghali JK, Herlitz J, et al. Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure:experiences from MERIT-HF. Am Heart J 2003;146:721–728.

    Article  PubMed  CAS  Google Scholar 

  23. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 1993;270:1589–1595.

    Article  PubMed  CAS  Google Scholar 

  24. Ryden L, Ariniego R, Arnman K, et al. A double-blind trial of metoprolol in acute myocardial infarction. N Engl J Med 1983;308:614–618.

    Article  PubMed  CAS  Google Scholar 

  25. The CAPRICORN investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001;357:1385–1390.

    Article  Google Scholar 

  26. McMurray J, Kober L, Robertson M, et al. Antiarrhythmic effect of carvedilol after acute myocardial infarction:results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol 2005;45:525–530.

    Article  PubMed  CAS  Google Scholar 

  27. Hjalmarson A, Goldstein S, Fagerberg B, et al., for the MERIT-HF study group. Effects of controlled-release metoprolol on total rortality, hospitalizations, and well-being in patients with heart failure: the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) JAMA 2000;283:1295–1302.

    Article  PubMed  CAS  Google Scholar 

  28. Janosi A, Ghali JK, Herlitz J, et al., on behalf of the MERIT-HF study group. Meto-prolol XL/CR in post-myocardial infarction patients with chronic heart failure: Experiences from MERIT-HF. Am Heart J 2003;146:721–728.

    Article  PubMed  CAS  Google Scholar 

  29. Squire I. Neurohormonal intervention to reduce sudden cardiac death in heart failure: what is the optimal pharmacologic strategy? Heart Fail Rev 2004;9: 337–345.

    Article  PubMed  CAS  Google Scholar 

  30. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators. N Engl J Med 1992;327:669–677.

    PubMed  CAS  Google Scholar 

  31. Ambrosioni E, Borghi C, Magnani B, for the survival of myocardial infarction long-term evaluation (SMILE) investigators. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995;332:80–85.

    Article  PubMed  CAS  Google Scholar 

  32. Kober L, Torp-Pedersen C, Carlsen JE, et al., for the trandolapril cardiac evaluation (TRACE) study group. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995;333:1670–1676.

    Article  PubMed  CAS  Google Scholar 

  33. Cleland JG, Erhardt L, Murray G, et al., on behalf of the AIRE study investigators. Effect of ramipril on morbidity and mode of death among survivors of acute myo-cardial infarction with clinical evidence of heart failure. Eur Heart J 1997;18:41–51.

    PubMed  CAS  Google Scholar 

  34. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383– 1389.

    Google Scholar 

  35. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators. N Engl J Med 1996;335:1001–1009.

    Article  PubMed  CAS  Google Scholar 

  36. The Long-term Intervention with Pravastatin in Ichaemic Disease (LIPID) study group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349–1357.

    Article  Google Scholar 

  37. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas coronary atherosclerosis prevention study. JAMA 1998;279:1615–1622.

    Article  PubMed  CAS  Google Scholar 

  38. Mitchell LB, Powell JL, Gillis AM, et al. Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the antiarrhythmics versus implantable defibrillators (AVID) trial. J Am Coll Cardiol 2003;42:81–87.

    Article  PubMed  CAS  Google Scholar 

  39. Vyas AK, Guo H, Moss AJ, et al., for the MADIT-II research group. Reduction in ventricular tachyarrhythmias with statins in the multicenter automatic defibrillator implantation trial (MADIT)–II. J Am Coll Cardiol 2006;47:769–773.

    Article  PubMed  CAS  Google Scholar 

  40. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309–1321.

    Article  PubMed  CAS  Google Scholar 

  41. Pitt B, Zannad F, Bittman R, et al. The EPHESUS Trial: evaluation of eplerenone in the subgroup of patients with baseline left ventricular ejection fraction =30%. J Cardiac Fail 2003;9(Suppl 1):S57.

    Article  Google Scholar 

  42. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781–788.

    PubMed  CAS  Google Scholar 

  43. Waldo AL, Camm AJ, de Ruyter H, et al., for the SWORD investigators. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996;348:7–12.

    Article  PubMed  CAS  Google Scholar 

  44. Julian DG, Prescott RJ, Jackson FS, et al. Controlled trial of sotalol for one year after myocardial infarction. Lancet 1982;1(8282):1142–1147.

    Article  PubMed  CAS  Google Scholar 

  45. Kober L, Thomsen PEB, Moller M, et al., on behalf of the Danish investigators of arrhythmia and mortality on dofetilide (DIAMOND) study group. Effect of dofeti-lide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomized trial. Lancet 2000;356:2052–2058.

    Article  PubMed  CAS  Google Scholar 

  46. Camm AJ, Pratt CM, Schwartz PJ, et al., on behalf of the azimilide post infarct survival evaluation (ALIVE) investigators. Mortality in patients after a recent myocardial infarction. A randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation 2004;109:990–996.

    Article  PubMed  Google Scholar 

  47. Julian DG, Camm AJ, Frangin G, et al., for the European myocardial infarct amioda-rone trial investigators. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction. Lancet 1997;349:667–674.

    Article  PubMed  CAS  Google Scholar 

  48. Cairns JA, Connolly SJ, Roberts R, et al., for the Canadian amiodarone myocardial infarction arrhythmia trial investigators. Randomised trial of outcome after myo-cardial infarction in patients with frequent or repetitive ventricular premature depo-larisations: CAMIAT. Lancet 1997;349:675–682.

    Article  PubMed  CAS  Google Scholar 

  49. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225–237.

    Article  PubMed  CAS  Google Scholar 

  50. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576–1583.

    Article  Google Scholar 

  51. Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748–754.

    PubMed  CAS  Google Scholar 

  52. Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297–1302.

    PubMed  CAS  Google Scholar 

  53. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibril-lator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933–1940.

    Article  PubMed  CAS  Google Scholar 

  54. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882–1890.

    Article  PubMed  CAS  Google Scholar 

  55. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877–883.

    Article  PubMed  Google Scholar 

  56. Solomon SD, Zelenkofske S, McMurray JJ, et al. Sudden death in patients with myo-cardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005;352:2581–2588.

    Article  PubMed  CAS  Google Scholar 

  57. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481–2488.

    Article  PubMed  CAS  Google Scholar 

  58. Raviele A, Bongiorni MG, Brignole M, et al. Early EPS/ICD strategy in survivors of acute myocardial infarction with severe left ventricular dysfunction on optimal beta-blocker treatment. The BEta-blocker STrategy plus ICD trial. Europace 2005;7: 27–337.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Medicine, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA

    Delia Cotiga MD & Kataneh Maleki MD

  2. Department of Cardiology, St. Luke's-Roosevelt Hospital Center Columbia University College of Physicians and Surgeons, New York, NY, USA

    Tina Sichrovsky MD & Suneet Mittal MD

Authors
  1. Delia Cotiga MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tina Sichrovsky MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kataneh Maleki MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Suneet Mittal MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cardiac Catheterization Laboratory and Interventional Cardiology, Department of Medicine, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA

    Mun K. Hong MD

  2. Cardiac Care Unit, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA

    Eyal Herzog MD, FACC

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Cotiga, D., Sichrovsky, T., Maleki, K., Mittal, S. (2008). Ventricular Arrhythmias in Patients After Myocardial Infarction. In: Hong, M.K., Herzog, E. (eds) Acute Coronary Syndrome. Springer, London. https://doi.org/10.1007/978-1-84628-869-2_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-869-2_18

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-868-5

  • Online ISBN: 978-1-84628-869-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation